AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)

Loading prices

Drugscience

Published November 13, 2026 · Updated November 14, 2026

The Uncertain Future of Ayahuasca: Reflections from the World Ayahuasca Forum - Drug Science

Read the full story at Drugscience

Ayahuasca, along with other sacred plant medicines and naturally occurring psychedelics more broadly, has never been more globalised or more studied.

Post on X

Share this story

Surfaced by 2 Google Alerts

Psychedelics
Psychedelics south america